bioRxivPhysiology
Organ protection by caloric restriction depends on activation of the de novo NAD+ synthesis pathway
M. R. Spaeth, K. J. R. Hoyer-Allo, M. Johnsen, M. Hoehne, C. Lucas, S. Brodesser, J.-W. Lackmann, K. Kiefer, F. C. Koehler, P. Schiller, T. Kubacki, F. Grundmann, T. Benzing, B. Schermer, V. Burst, R.-U. Mueller
Abstract
Therapeutic strategies to treat acute kidney injury (AKI) are lacking in clinical practice. Interestingly, preconditioning by hypoxia (HP) and caloric restriction (CR) is highly protective in rodent AKI models. However, the underlying molecular mechanisms of this process are unknown. A comparative transcriptome analysis of murine kidneys after HP and CR identified Kynureninase (KYNU) as a common downstream target. Using a newly generated KYNU-deficient mouse line, we show that KYNU strongly contributes to the protective effect of preconditioning. Metabolome, transcriptome and proteome analyses reveal the KYNU-dependent de novo nicotinamide adenine dinucleotide (NAD+) biosynthesis pathway as necessary for CR-associated maintenance of NAD+ levels. Importantly, the impact of CR on the de novo NAD+ biosynthesis pathway can be recapitulated in humans. These findings provide a valuable insight into the molecular mechanisms mediating protection upon preconditioning and point towards the de novo branch of NAD+ biosynthesis as a conserved target in nephroprotection.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- HNF4α mediated QPRT expression in the kidney facilitates resilience against acute kidney injury
A. J. Clark, M. C. Saade, … S. M. Parikh·bioRxiv·May 23, 2023
- Nicotinamide riboside: A promising therapy for MI-induced acute kidney injury by upregulating nicotinamide phosphoribosyltransferase-mediated NAD levels
Nada J. Habeichi, Ghadir Amin, … Fouad Anthony Zouein·Journal of the American Heart AssociationPeer-reviewed·Feb 26, 2025
- A systematic analysis of diet-induced nephroprotection reveals overlapping and conserved changes in cysteine catabolism
F. C. Koehler, C.-Y. Fu, … R.-U. Mueller·Translational ResearchPeer-reviewed·Jun 1, 2022
- NAD+ activates renal metabolism and protects from chronic kidney disease in a model of Alport syndrome
Bryce A. Jones, Debora L. Gisch, … Moshe Levi·JCI InsightPeer-reviewed·Mar 9, 2025
- Kynurenic acid, a key L-tryptophan-derived metabolite, protects the heart from an ischemic damage
E. Bigelman, M. Pasmanik-Chor, … M. Entin Meer·bioRxiv·May 17, 2022
- Peripheral CB1R Blockade Suppresses AKI-to-CKD Maladaptive Repair
Ariel Rothner, Liad Hinden, … Joseph Tam·bioRxiv·Aug 5, 2026